Patents by Inventor Valerie A. Vaillancourt

Valerie A. Vaillancourt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9221835
    Abstract: The invention recites spirocyclic derivatives of Formula (V.1) or (V.2), stereoisomers thereof, veterinary acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide for an animal. The variables A, B, V, Z, Y, W1, W2, W3, R1a, R1b, R1c, R2, R3, R4, n, and “ - - - ” are as described herein.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: December 29, 2015
    Assignee: Zoetis Services LLC
    Inventors: Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Patent number: 9131697
    Abstract: The invention recites spirocyclic isoxazoline derivatives of Formula (1) stereoisomers thereof, veterinary or pharmaceutical acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide in an animal. The variables W1, W2, W3, W, X, R1a, R1b, R1c, R2, R3, R4, and n are as described herein.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: September 15, 2015
    Assignee: Zoetis Services LLC
    Inventors: Sanjay Menon, Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Patent number: 9133172
    Abstract: This invention recites dihydrofuran substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. The substituents A, R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: September 15, 2015
    Assignee: Zoetis Services LLC
    Inventors: Nathan Anthony Logan Chubb, Valerie A. Vaillancourt
  • Publication number: 20150210710
    Abstract: The invention recites spirocyclic derivatives of Formula (V.1) or (V.2), stereoisomers thereof, veterinary acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide for an animal. The variables A, B, V, Z, Y, W1, W2, W3, R1a, R1b, R1c, R2, R3, R4, n, ad “ - - -” are as described herein.
    Type: Application
    Filed: September 4, 2013
    Publication date: July 30, 2015
    Inventors: Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Patent number: 9073912
    Abstract: This invention recites substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in animals. The substituents A, B, R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: July 7, 2015
    Assignee: Zoetis Services LLC
    Inventors: Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Publication number: 20150181882
    Abstract: The invention recites spirocyclic isoxazoline derivatives of Formula (1) stereoisomers thereof, veterinary or pharmaceutical acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide in an animal. The variables W1, W2, W3, W, X, R1a, R1b, R1c, R2, R3, R4, and n are as described herein.
    Type: Application
    Filed: September 4, 2013
    Publication date: July 2, 2015
    Inventors: Sanjay Menon, Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Patent number: 9061013
    Abstract: This invention recites isoxazoline substituted derivatives of Formula (1) stereoisomers thereof, geometric isomers thereof, veterinarily acceptable salts 5 thereof, compositions thereof, and their use as a parasiticide in animals. The variables A, W, R 1a, R 1b, R 1c, R 2, R 3, R 5, and n are as described herein.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: June 23, 2015
    Assignee: Zoetis LLC
    Inventors: Valerie A. Vaillancourt, John A. Wendt, Graham M. Kyne, Sanjay Menon
  • Publication number: 20150119377
    Abstract: This invention recites substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in animals. The substituents A, B, R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Application
    Filed: May 6, 2013
    Publication date: April 30, 2015
    Inventors: Susan M. K. Sheehan, Valerie A. Vaillancourt
  • Publication number: 20150038440
    Abstract: This invention recites dihydrofuran substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. The substituents A, R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Application
    Filed: January 29, 2013
    Publication date: February 5, 2015
    Inventors: Nathan Anthony Logan Chubb, Valerie A. Vaillancourt
  • Publication number: 20140011758
    Abstract: This invention recites isoxazoline substituted derivatives of Formula (1) stereoisomers thereof, geometric isomers thereof, veterinarily acceptable salts 5 thereof, compositions thereof, and their use as a parasiticide in animals. The variables A, W, R 1a, R 1b, R 1c, R 2, R 3, R 5, and n are as described herein.
    Type: Application
    Filed: March 8, 2012
    Publication date: January 9, 2014
    Inventors: Valerie A. Vaillancourt, John A. Wendt, Graham M. Kyne, Sanjay Menon
  • Patent number: 8466115
    Abstract: The invention recites spirocyclic isoxazoline derivatives of Formula (V.1), Formula (V.2), Formula (V.1.1), and Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide in an animal. The variables A, V, Z, W1, W2, W3, W, Y, X, R1a, R1b, R1c, R2, R3, R4, n, and “” are as described herein.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: June 18, 2013
    Assignee: Zoetis LLC
    Inventors: Michael Curtis, Sanjay Menon, Valerie A. Vaillancourt, Nathan Anthony Logan Chubb, Denis Billen, Sean David William Greenwood, Timothy Lee Stuk
  • Patent number: 8415310
    Abstract: This invention recites isoxazoline substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: April 9, 2013
    Assignee: AH USA 42 LLC
    Inventors: Valerie A. Vaillancourt, Nathan Anthony Logan Chubb, Michael Curtis, William Howson, Graham M. Kyne, Sanjay Menon, Susan M. K. Sheehan, Donald J. Skalitzky, John A. Wendt
  • Publication number: 20120232026
    Abstract: The invention recites spirocyclic isoxazoline derivatives of Formula (V.1), Formula (V.2), Formula (V.1.1), and Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide in an animal. The variables A, V, Z, W1, W2, W3, W, Y, X, R1a, R1b, R1c, R2, R3, R4, n, and “” are as described herein.
    Type: Application
    Filed: March 8, 2012
    Publication date: September 13, 2012
    Applicant: PFIZER INC.
    Inventors: Michael Curtis, Sanjay Menon, Valerie A. Vaillancourt, Nathan Anthony Logan Chubb, Denis Billen, Sean David William Greenwood, Timothy Lee Stuk
  • Publication number: 20120035122
    Abstract: This invention recites isoxazoline substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.
    Type: Application
    Filed: August 4, 2011
    Publication date: February 9, 2012
    Inventors: Valerie A. Vaillancourt, Nathan Anthony Logan Chubb, Michael Curtis, William Howson, Graham M. Kyne, Sanjay Menon, Susan M. K. Sheehan, Donald J. Skalitzky, John A. Wendt
  • Patent number: 6903097
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: June 7, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Fred L. Ciske, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt
  • Publication number: 20040180910
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: March 29, 2004
    Publication date: September 16, 2004
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • Publication number: 20040142928
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 23, 2003
    Publication date: July 22, 2004
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Patent number: 6730682
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: May 4, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt
  • Patent number: 6727248
    Abstract: The present invention discloses disubstiuted 4-oxo-1,4-dihydro-3-quinolinecarboxamide derivatives. The compounds are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: April 27, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Valerie A. Vaillancourt, Audris Huang
  • Patent number: 6693114
    Abstract: A compound of formula III: or a pharmaceutically acceptable salt thereof wherein, the variables are as in the specification is provided. The compounds are particularly effective in the treatment or prevention of herpes viruses.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: February 17, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Valerie A. Vaillancourt, Atli Thorarensen